BIOHARVEST SCIENCES INC.
BHST · XNASCIK 1723464fmd_1QCHCN69W20X9W8EMTS7GEP0Q3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Dec 31, 2025, 3 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 13 | 25 | 35 |
| Cost of revenue | 7 | 11 | 14 |
| Gross profit | 6 | 14 | 20 |
| Research and development | 3 | 5 | 5 |
| Selling, general and administrative | 12 | 16 | 21 |
| Total operating expenses | 16 | 21 | 26 |
| Operating income | (10) | (7) | (6) |
| Income before taxes | (13) | (13) | (11) |
| Income tax expense | 0 | (0) | (0) |
| Net income from continuing operations | (13) | (13) | (11) |
| Net income | (13) | (13) | (11) |